Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men

Experimental Biology and Medicine

Volumn 242, Issue 14, 2017, Pages 1412-1423

  Bukowska, Alicja ^a   Spiller, L ^b   Wolke, C ^c   Lendeckel, U ^c   Weinert, S ^a   Hoffmann, J ^a   Bornfleth, P ^a   Kutschka, I ^a   Gardemann, A ^a   Isermann, B ^a   Goette, A ^a,d  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^d St Vincenz Hospital   (Germany)

Author keywords

angiotensin converting enzyme 2; atrial remodeling; estrogen; estrogen receptors; Human atrial myocardium; renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; ACE PROTEIN, HUMAN; ESTROGEN RECEPTOR;

AGED; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART; HEART RIGHT ATRIUM; HEART SURGERY; HUMAN; HUMAN TISSUE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SLICE; UPREGULATION; WESTERN BLOTTING; CARDIAC MUSCLE; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENE EXPRESSION PROFILING; MALE; METABOLISM; PATHOLOGY;

AGED; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, ESTROGEN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 85026773887     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370217718808     Document Type: Article

References (60)

1. Knowlton AA, Lee AR. Oestrogen and the cardiovascular system. Pharmacol Ther 2012; 135: 54–70.
2. Bjornstrom L, Sjoberg M. Mechanisms of oestrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005; 19: 833–42.
3. Ueda K, Karas RH. Emerging evidence of the importance of rapid, non-nuclear oestrogen receptor signaling in the cardiovascular system. Steroids 2013; 7: 589–96.
4. Simoncini T, Varone G, Fornari L, Mannella P, Luisi M, Labrie F, Genazzani AR. Genomic and nongenomic mechanisms of nitric oxide synthesis induction in humanendothelial cells by a fourth-generation selective oestrogen receptor modulator. Endocrinology 2002; 143: 2052–61.
5. Grohé C, Kahlert S, Löbbert K, Stimpel M, Karas R, Vetter H, Neyses L. Cardiac myocytes and fibroblasts contain functional oestrogen receptors. FEBS Lett 1997; 416: 107–12.
6. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, Vetter H, Grohé C. 17 Beta-oestradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res 1999; 43: 666–74.
7. de Jager T, Pelzer T, Müller-Botz S, Imam A, Muck J, Neyses L. Mechanisms of oestrogen receptor action in the myocardium, Rapid gene activation via the ERK1/2 pathway and serum response elements. J Biol Chem 2001; 276: 27873–80.
8. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedling S, Grohe C, Force T, Mendelsohn ME, Karas RH. 17beta-oestradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 2004; 9: 692–9.
9. Donaldson C, Eder S, Baker C, Aronovitz MJ, Weiss AD, Hall-Porter M, Wang F, Ackerman A, Karas RH, Molkentin JD, Patten RD. Oestrogen attenuates left ventricular and cardiomyocyte hypertrophy by an oestrogen receptor-dependent pathway that increases calcineurin degradation. Circ Res 2009; 104: 265–75.
10. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 2002; 53: 672–7.
11. Bechtloff R, Goette A, Bukowska A, Kähne T, Peters B, Huth C, Wolke C, Lendeckel U. Gender and age-dependent differences in the bradykinin-degradation within the pericardial fluid of patients with coronary artery disease. Int J Cardiol 2011; 146: 164–70.
12. Hilliard LM, Sampson AK, Brown RD, Denton KM. The “his and hers” of the renin angiotensin system. Curr Hypertens Rep 2013; 15: 71–9.
13. Goette A, Bukowska A, Lendeckel U, Erxleben M, Hammwöhner M, Strugala D, Pfeiffenberger J, Röhl FW, Huth C, Ebert MP, Klein HU, Röcken C. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. Circulation 2008; 117: 732–42.
14. Goette A, Ittenson A, Hoffmanns P, Reek S, Hartung W, Klein H, Ansorge S, Geller JC. Increased expression of P-selectin in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol 2000; 23(11 Pt 2): 1872–5.
15. Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 2003; 60: 315–25.
16. Tsai CT, Lai LP, Hwang JJ, Chen WP, Chiang FT, Hsu KL, Tseng CD, Tseng YZ, Lin JL. Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation. J Hypertens 2008; 26: 570–82.
17. Goette A, Staack T, Rocken C, Arndt M, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000; 35: 1669–77.
18. Bukowska A, Zacharias I, Weinert S, Skopp K, Hartmann C, Huth C, Goette A. Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue. Eur J Pharmacol 2013; 718: 114–23.
19. Bussek A, Wettwer E, Christ T, Lohmann H, Camelliti P, Ravens U. Tissue slices from adult mammalian hearts as a model for pharmacological drug testing. Cell Physiol Biochem 2009; 24: 527–36.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402–8.
21. Nordmeyer J, Eder S, Mahmoodzadeh S, Martus P, Fielitz J, Bass J, Bethke N, Zurbrügg HR, Pregla R, Hetzer R, Regitz-Zagrosek V. Upregulation of myocardialestrogen receptors in human aortic stenosis. Circulation 2004; 110: 3270–5.
22. Mahmoodzadeh S, Eder S, Nordmeyer J, Ehler E, Huber O, Martus P, Weiske J, Pregla R, Hetzer R, Regitz-Zagrosek V. Estrogen receptor alpha up-regulation and redistribution in human heart failure. FASEB J 2006; 20: 926–34.
23. Pugach EK, Blenck CL, Dragavon JM, Langer SJ, Leinwand LA. Estrogen receptor profiling and activity in cardiac myocytes. Mol Cell Endocrinol 2016; 431: 62–70.
24. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M, Gustafsson JA. Estrogen receptors: how do theysignal and what are their targets. Physiol Rev 2007; 87: 905–31.
25. Monteiro R, Teixeira D, Calhau C. Estrogen signaling in metabolic inflammation. Mediators Inflamm 2014; 2014: 615917–615917.
26. Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez JL, Candas B. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 1998; 63: 322–8.
27. Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, Speed C, Jones M. Aromatase – a brief overview. Annu Rev Physiol 2002; 64: 93–127.
28. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003; 86: 225–30.
29. Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocrine Rev 2013; 34: 309–38.
30. Paradis P, Dali-Youcef N, Paradis FW, Thibault G, Nemer M. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodelling. Proc Natl Acad Sci U S A 2000; 97: 931–6.
31. Shaltout HA, Westwood BM, Averill DB, Ferrario CM, Figueroa JP, Diz DI, Rose JC, Chappell MC. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 2007; 292: F82–91.
32. Brosnihan KB, Senanayake PS, Li P, Ferrario CM. Bi-directional actions of oestrogen on the renin-angiotensin system. Braz J Med Biol Res 1999; 32: 373–81.
33. Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB. Oestrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 1999; 33: 323–8.
34. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutrition 2004; 134: 489–92.
35. Goraya TY, Kessler SP, Kumar RS, Douglas J, Sen GC. Identification of positive and negative transcriptional regulatory elements of the rabbit angiotensin-converting enzyme gene. Nucleic Acids Res 1994; 22: 1194–201.
36. Howard T, Balogh R, Overbeek P, Bernstein KE. Sperm-specific expression of angiotensin-converting enzyme (ACE) is mediated by a 91-basepair promoter containing a CRE-like element. Mol Cell Biol 1993; 13: 18–27.
37. Shai SY, Langford KG, Martin BM, Bernstein KE. Genomic DNA 59 to the mouse and human angiotensin-converting enzyme genes contains two distinct regions of conserved sequence. Biochem Biophys Res Commun 1990; 167: 1128–33.
38. Zhou Y, Sun Z, Means AR, Sassone-Corsi P, Bernstein KE. cAMP response element modulator tau is a positive regulator of testis angiotensin converting enzyme transcription. Proc Natl Acad Sci USA 1996; 93: 12262–6.
39. Joyner J, Neves LA, Granger JP, Alexander BT, Merrill DC, Chappell MC, Ferrario CM, Davis WP, Brosnihan KB. Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol 2007; 293: R169–77.
40. Neves LA, Stovall K, Joyner J, Valdés G, Gallagher PE, Ferrario CM, Merrill DC, Brosnihan KB. ACE2 and ANG-(1-7) in the rat uterus during early and late gestation. Am J Physiol Regul Integr Comp Physiol 2008; 294R: 151–61.
41. Ji H, Menini S, Zheng W, Pesce C, Wu X, Sandberg K. Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17 beta-ooestradiol regulation of renal pathology in renal wrap hypertension in rats. Exp Physiol 2008; 93: 648–57.
42. Shenoy V, Grobe JL, Qi Y, Ferreira AJ, Fraga-Silva RA, Collamat G, Bruce E, Katovich MJ. 17beta-Oestradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats. Peptides 2009; 30: 2309–15.
43. Ferreira AJ, Murça TM, Fraga-Silva RA, Castro CH, Raizada MK, Santos RA. New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis. Int J Hypertens 2012; 2012: 147825–147825.
44. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003; 107: 2926–31.
45. Freshour JR, Chase SE, Vikstrom KL. Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice. Am J Physiol Heart Circ Physiol 2002; 283: H1997–2003.
46. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75: 977–84.
47. Proudler AJ, Ahmed AI, Crook D, Fogelman I, Rymer JM, Stevenson JC. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 1995; 346: 89–90.
48. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. Effects of 17beta-oestradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996; 98: 36–42.
49. Pfeilschifter J, Köditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90–119.
50. Simoncini T, Maffei S, Basta G, Barsacchi G, Genazzani AR, Liao JK, De Caterina R. Oestrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res 2000; 87: 19–25.
51. Pelzer T, Neumann M, de Jager T, Jazbutyte V, Neyses L. Oestrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by oestrogen receptor-alpha and –beta. Biochem Biophys Res Commun 2000; 286: 1153–7.
52. Darabi M, Ani M, Movahedian A, Zarean E, Panjehpou M, Rabbani M. Effect of hormone replacement therapy on total serum anti-oxidant potential and oxidized ldl/ß2-glycoprotein i complexes in postmenopausal women. Endocrine J 2010; 57: 1029–34.
53. Campos C, Casali KR, Baraldi D, Conzatti A, Araújo AS, Khaper N, Llesuy S, Rigatto K, Belló-Klein A. Efficacy of a low dose of oestrogen on antioxidant defenses and heart rate variability. Oxid Med Cell Longev 2014; 2014: 218749–218749.
54. Campos C, Sartorio CL, Casali KR, Fernandes RO, Llesuy S, da Rosa Araujo AS, Belló-Klein A, Rigatto KV. Low dose oestrogen is as effective as high dose treatment in rats with postmenopausal hypertension. J Cardiovasc Pharmacol 2014; 63: 144–51.
55. Bukowska A, Schild L, Keilhoff G, Hirte D, Neumann M, Gardemann A, Neumann KH, Röhl FW, Huth C, Goette A, Lendeckel U. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia. Exp Biol Med 2008; 233: 558–74.
56. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397–402.
57. Du XJ. Gender modulates cardiac phenotype development in genetically modified mice. Cardiovasc Res 2004; 63: 510–9.
58. Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R. Sex and gender differences in myocardial hypertrophy and heart failure. Circ J 2010; 74: 1265–73.
59. Park JB, Zhang H, Lin CY, Chung CP, Byun Y, Park YS, Yang VC. Simvastatin maintains osteoblastic viability while promoting differentiation by partially regulating the expressions of estrogen receptors α. J Surg Res 2012; 174: 278–83.
60. Small W, Jr Molteni A, Kim YT, Taylor JM, Chen Z, Ward WF. Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture. Breast Cancer Res Treat 1997; 44: 217–24.